Catalent | CTLT - Sales Revenues


Catalent reported $1.02B in Sales Revenues for its fiscal quarter ending in September of 2024.



Sales Change Date
Agilent USD 1.86B 123M Sep/2025
AstraZeneca USD 15.5B 313M Dec/2025
Bristol-Myers Squibb USD 12.5B 300M Dec/2025
Bruker USD 977.2M 116.7M Dec/2025
Centene USD 49.73B 40M Dec/2025
Charles River Laboratories USD 1000M 32.14M Sep/2025
Cigna USD 72.47B 2.77B Dec/2025
Danaher USD 6.84B 790M Dec/2025
Dentsply International USD 904M 32M Sep/2025
Elevance Health USD 49.3B 790M Dec/2025
Eli Lilly USD 19.3B 1.7B Dec/2025
Glaxosmithkline GBP 11.52B 3.54B Sep/2025
Hologic USD 1.05B 0 Dec/2025
Humana USD 32.52B 130M Dec/2025
Illumina USD 1.16B 80M Dec/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
IQVIA Holdings USD 4.36B 260M Dec/2025
J&J USD 24.6B 610M Dec/2025
Laboratory Of America USD 3.56B 30M Sep/2025
Lonza CHF 3.58B 63M Jun/2025
McKesson USD 106.16B 3.01B Dec/2025
Merck EUR 5.32B 890M Sep/2025
Merck USD 16.4B 880M Dec/2025
Mettler Toledo International USD 1.13B 100M Dec/2025
Novartis USD 13.91B 144M Sep/2025
Pfizer USD 17.58B 880M Dec/2025
Quest Diagnostics USD 2.81B 10M Dec/2025
Repligen USD 189M 7M Sep/2025
Revvity USD 772.06M 73.06M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Supernus Pharmaceuticals USD 192.1M 26.6M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
UnitedHealth USD 113.2B 0 Dec/2025
Waters USD 932M 132M Dec/2025
West Pharmaceutical Services USD 805M 400K Dec/2025